InMed Issues Annual Letter to Shareholders Highlighting Key Accomplishments from 2021 and Providing 2022 Outlook Jan 5, 2022
InMed Pharmaceuticals Sees Historic Volume As It Enters Commercial Stage Of Bulk Cannabinoid Sales Nov 18, 2021
InMed Pharmaceuticals Reports First Quarter Fiscal 2022 Financial Results and Provides Business Update Nov 10, 2021
InMed Pharmaceuticals Makes Noise With Patent Application & Acquisition: Cannabis Stock Investing Nov 9, 2021
InMed Pharmaceuticals Reports Full Year Fiscal 2021 Financial Results and Provides Business Update Sep 24, 2021
InMed Pharmaceuticals Positioned For Growth As Cannabinoid Supply Sales Poised For Imminent “Take Off” Sep 22, 2021
InMed Pharmaceuticals Signs Definitive Agreement to Acquire BayMedica, a Leading Commercial Manufacturer of Rare… Sep 13, 2021
